Sent: 10/23/2006 6:10:43 PMSubject: Current Controlled Trials Update October 2006
Tuesday 24 October 2006
In this issue...
2006 Update of the NHS Trusts Clinical Trials
Register
- The 2006 Update of the NHS Trusts Clinical Trials Register is now available online at http://www.controlled-trials.com/mrct/
- The 2006 Update adds 268 randomised controlled trials to the ones identified in 2003, 2004 and 2005, bringing the total to over 1400 trial records.
- The NHS Trusts Clinical Trials Register includes the following randomised controlled trials:
- Trials taking place in England
- With an end date greater than 31 March 2003
- In a location that is the lead centre in the case of a multicentre trial
- For which all research costs have been met by the NHS Trust.
Wellcome Trust Register launched
- Current Controlled Trials is pleased to announce that the Wellcome Trust trial register is now hosted in the metaRegister of Controlled Trials (http://www.controlled-trials.com/mrct/).
- This allows the Wellcome Trust to pool their register of trials with other registers in the metaRegister, enabling visitors to search across a number of major international registers in a one-stop environment.
News from ISRCTN
- ISRCTN registration details are now listed by MEDLINE/PubMed in their Secondary ID source tags.
- Links from the PubMed Citation Display will shortly allow users to access the ISRCTN record with a direct link.
- The link menu from the Citation Display also offers a choice to search the ISRCTN in PubMed and retrieve other citations having the same number.
Faculty of 1000 Medicine: offering multiple perspectives of a single trial
A recent article in the Lancet comparing haemodiafiltration to haemodialysis has attracted evaluations from Faculty Members in three different Faculties:
- Patrick Neligan from the Anesthesiology & Pain Management Faculty felt the findings were controversial, given their "sobering figures" on mortality, but said that the article was "unlikely ... (to) dramatically change practice"
- Greg McAnulty from the Critical Care & Emergency Medicine Faculty felt that because the trial showed an "equivalence in outcome" it confirmed what we already knew
- And Andrew Davenport from the Nephrology Faculty found the article controversial because by saying the "the modality of renal replacement therapy ... did not impact on patient survival" it refuted existing thinking
Gathering different perspectives on a single article is a key component of Faculty of 1000 Medicine. To learn more, take a free trial.
Trials: call for papers for articles covering trial results
Trials is an open access, open peer-reviewed, online journal that publishes articles concerned with randomised controlled trials in any discipline related
to health care. The journal encompasses articles on any aspect of the design, analysis and performance of a trial, and is keen to encourage articles covering trial results, whether positive or negative, from any stage of the trial.See http://www.trialsjournal.com/info/about/ for further details of the scope of the journal.
Trials is published by BioMed Central Ltd (http://biomedcentral.com), a sister company of Current Controlled Trials Ltd.
A reminder of our services
The Current Controlled Trials website allows you to search freely for trial information, to register your trial via the ISRCTN unique trial ID scheme (apply online) or to pool your existing register in the metaRegister of Controlled Trials. In addition, trial protocol and/or trial results can be published in the new Trials journal (see above) or in one of the 160+ open access journals published by Current Controlled Trial's sister company, BioMed Central.
You have received this message because you have requested updates from Current Controlled Trials.
Your registered e-mail address is: [EMAIL PROTECTED]
To unsubscribe send a blank email to: [EMAIL PROTECTED]To start receiving Current Controlled Trials updates please send a blank email to:
[EMAIL PROTECTED]
Title: Current Controlled Trials Update
FYI - INTERESTING WEB SITE
----- Original Message -----